Sharepoint Solutions
PRODUCTS
-
The TWIST™ Mini Liposome Extruder System is an all-inclusive modular liposome extrusion system. The intuitive design allows novice and expert users the ability to create liposome particles ranging from 50 nm to 10 um in diameter. With the heat block and extruder base, users have extended liposome creation capabilities and an easy, ergonomic set up. The TWIST™ System is the perfect solution for small scale R&D and liposome exploration projects.
-
We want your product to move through the regulatory process, gaining approvals and ultimately helping patients. Using our industry leading knowledge and skills, we will meet you where you are – gaining approval: for the first in human trials, in development, at scientific advice, at the end of phase 2, or post approval. At every level, our scientific expertise and in-depth knowledge of therapeutic backgrounds have guided every client we have to a successful outcome.
-
With over 130 in-life gene therapy studies completed, Altasciences is a leading expert in gene therapy research, with integrated preclinical and bioanalytical capabilities.
-
Help your patients make informed decisions without burying them in paper
With electronic informed consent (eConsent) software, your patients can access consent forms using any device they choose. And because it’s part of TrialKit’s unified platform, both your patients and your study team get a seamless experience.
-
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and emerging contaminants don’t break down easily, making them difficult to remove from our water sources. Newterra offers pre-engineered adsorber filtration systems for effective removal at any flow rate.
WHITE PAPERS AND CASE STUDIES
-
The Foundation Of Peak Performance
In this case study, read about an underdrain system that continues to operate as expected after 16 years of operation and appears to be in perfect condition.
-
Navigating Digital Transformation For Pharmaceutical CDMOs
Discover how CDMOs can modernize operations, safeguard data integrity, and improve audit readiness with practical strategies for connecting systems and reducing validation burdens.
-
Navigating The Translation To Clinic: Future-Proof Your Plasmid Products
Future-proofing products with strategies that reduce risk and timelines for later stages can be resource-intensive but add significant value. Explore the challenges encountered progressing from development to clinic.
-
Early-Stage Development In Rare Pediatric Oncology
Learn about the strategic approach a biotechnology company utilized to address significant hurdles in launching a Phase 1 clinical trial for a novel therapy targeting a rare pediatric cancer.
-
Mobile Application Considerations For Clinical Trials And Beyond
Delve into fundamental definitions, navigate through the regulatory landscape, and examine common applications of mobile apps in research.
-
Medical Writing Support Relieves A Burdensome Review
Unearth how medical writing and project management teams were able to streamline the development and review of a critical marketing application document.
-
GSK And Medable Discuss The Next Phase Of DCTs
GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
-
Success Factors For Launching Products With Orphan Drug Designation
Orphan drug designation offers a number of financial incentives to pharmaceutical companies. Learn more about the potential hurdles of orphan drug development and the opportunities to maximize your success.
-
Project Orbis Drug Registration 2025
Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.
-
The Key To Accelerating RNA-LNP Drug Development
Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Unveiling The Critical Role of Sleep In Clinical Studies
Explore the critical role of sleep in clinical trials and its impact on health outcomes, emphasizing the need to address sleep disturbances for more effective and reliable research.
NEWS
-
FAU Tells 'Story' Of Atlantic's Sargassum Surge Using 40 Years Of Data8/28/2025
Researchers at Florida Atlantic University’s Harbor Branch Oceanographic Institute have released a landmark review tracing four decades of changes in pelagic sargassum – free-floating brown seaweed that plays a vital role in the Atlantic Ocean ecosystem.
-
WRF Seeks Pre-Proposals For High-Priority Utility Research2/6/2025
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program.
-
Biden-Harris Administration Announces Over $124M For Tennessee Drinking Water, Wastewater And Stormwater Infrastructure Upgrades As Part Of President Biden's Investing In America Agenda2/23/2024
The U.S. Environmental Protection Agency (EPA) announced over $124M from President Biden’s Investing in America agenda for Tennessee drinking water and clean water infrastructure upgrades.
-
New Study Highlights Rewilding's Role In Tackling Flood And Drought Challenges2/26/2024
Rewilding is the large-scale restoration of ecosystems to the point where nature is allowed to take care of itself.
-
Biden-Harris Administration Announces $3.6B For Water Infrastructure Through Investing in America Agenda10/23/2024
the U.S. Environmental Protection Agency announced $3.6B in new funding under the Biden-Harris Administration’s Bipartisan Infrastructure Law to upgrade water infrastructure and keep communities safe.